Back

Empagliflozin for prevention of acute kidney injury in patients with type 2 diabetes mellitus undergoing extracorporeal on-pump CABG: The POST-CABGDM trial

2 September 2024 (08:37 - 08:48)
Organised by: Logo
Congress Presentation Part of: Smaller trials and trial updates on shock, surgery, and other interventions Revascularisation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Fabio Grunspun Pitta

Albert Einstein Israelite Hospital, Sao Paulo (Brazil)

7 More presentations in this session

Presentation thumbnail
Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock - 12 months results of the ECLS-SHOCK trial
Professor S. Desch (Leipzig, DE)
Slides Video
Presentation thumbnail
Impact of baseline surgical risk on the treatment effect of PCI and CABG in ischemic left ventricular systolic dysfunction: results of the REVIVED-BCIS2 and STICH randomized controlled trials
Doctor G. Marquis-Gravel (Montreal, CA)
Slides Video
Presentation thumbnail
Comparative Effectiveness of Percutaneous and Surgical Revascularisation in Ischaemic Left Ventricular Systolic Dysfunction: Combined Patient-Level Analysis of the REVIVED-BCIS2 and STICH Trials
Doctor M. Ryan (London, GB)
Slides Video
Presentation thumbnail
Temporary mechanical circulatory support in infarct-related cardiogenic shock - An individual patient data meta-analysis of all randomized trials with 6-month follow-up
Professor H. Thiele (Leipzig, DE)
Slides Video
Presentation thumbnail
Urgent surgery compared to fibrinolytic therapy for the treatment of left-sided mechanical valve thrombosis (SAFE-PVT): a randomized controlled trial
Professor G. Karthikeyan (New Delhi, IN)
Slides Video

Access the full session

Session thumbnail
Smaller trials and trial updates on shock, surgery, and other interventions
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 08:37 CET
You may be interested in
thumbnail
Congress Presentation
SGLT2-'eyes' on the reno-protection prize: reduction of post-PCI contrast-associated AKI in diabetic patients using SGLT2 inhibitors
thumbnail
Congress Session
Smaller trials and trial updates on shock, surgery, and other interventions
thumbnail
Congress Session
Late-Breaking Clinical Trials: cardiovascular risk and prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources